Mirxes’ HK IPO: Pioneering miRNA Diagnostics with Strong Investor Backing

1. IPO Details Purpose of IPO: Mirxes aims to raise approximately HKD 1.086 billion (USD 139 million) through its IPO. The proceeds are intended to support the commercialization of its gastric cancer test, further...